person

Maria Judit M.

Country
Hungary
Department
Genomikai Medicina és Ritka Betegségek Intézete

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
104
Sites with multiple studies

Has run more than one trial at 104 of 195 partner sites.

Specializations

Neuromuscular Disorders

The investigator specializes in treating various neuromuscular conditions, with particular emphasis on Duchenne Muscular Dystrophy and Late Onset Pompe Disease. Their research encompasses innovative therapeutic approaches for these progressive muscle disorders.

  • Muscular Dystrophy Management
  • Enzyme Replacement Therapy
  • Genetic Muscle Disorders

Their work includes evaluating novel treatments for patients with specific genetic mutations affecting muscle function.

Inflammatory Muscle Conditions

The investigator focuses on treating Idiopathic Inflammatory Myopathy (IIM), exploring both short-term and long-term therapeutic interventions. Their expertise extends to evaluating advanced immunomodulatory treatments for inflammatory muscle diseases.

  • Autoimmune Muscle Disorders
  • Immunotherapy Development
  • Chronic Inflammation Management

Their research encompasses subcutaneous treatment formulations and their efficacy in inflammatory muscle conditions.

Therapeutic Innovation

The investigator evaluates novel therapeutic approaches including subcutaneous formulations and combination therapies. Their work involves assessing both the safety and efficacy of experimental treatments for rare muscle disorders.

  • Drug Delivery Systems
  • Long-term Treatment Outcomes
  • Standard-of-Care Enhancement

Their research contributes to advancing treatment options for patients with rare and complex muscle disorders.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.